0
2023
Patient Controlled Analgesia Pumps Market

Patient Controlled Analgesia Pumps Market

by Type (Electronic and Wireless, Mechanical), by Application (Oncology and hematology, Gastroenterology, Others), by End user (Hospitals, Ambulatory surgical centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A13386
Jan 2023 | Pages: 235
Tables: 126
Charts: 59
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Patient Controlled Analgesia Pumps Market Research, 2031

The global patient controlled analgesia pumps market size was valued at $277.7 million in 2021, and is projected to reach $407.9 million by 2031, growing at a CAGR of 3.9% from 2022 to 2031. Patient controlled analgesia pumps are medical devices, which are used to deliver medications, such as pain relievers into a patient’s body at intervals in accurate dosages. The pump is attached to an intravenous (IV) line, which is a small, flexible tube inserted into a vein. Normally, this medication is administered when the button is pressed. These pumps are medical devices that delivers the medications into a patient’s body in controlled amounts. The infused medications play vital role in therapeutics or medical treatments, and are widely used in healthcare settings such as patient, outpatient, private clinics, and at-home settings.

The patient controlled analgesia pumps market slightly decreased during the lockdown period owing to decline in sales of patient controlled analgesia pumps. However, sure in the vaccination drive and increase in trend of home healthcare settings is expected to increase the growth of the patient controlled analgesia pumps market.

Patient Controlled Analgesia Pumps Market

The patient controlled analgesia pumps market is segmented into Type, Application and End user. These analgesic pumps help to manage the patient pain during and after surgery, for treatment of burns, treatment of chronic pain, and also used in pediatric patients. The applications of these analgesic pumps for delivery of medications such as morphine, fentanyl and hydromorphone. Patient controlled analgesia infusion pumps are available in electronic and mechanical pumps. Furthermore, patient-controlled analgesic pumps promote better patient management and care, thus offering several advantages in comparison to conventional modules. Key advantages of PCA include greater patient satisfaction, fewer post-operative complications, less sedation, improved quality of recovery, and less use of medication (as doses are set).

Market Dynamics

Rise in technological advancements for patient controlled analgesia pumps owing to massive pool of chronic diseases creates an opportunity for the patient controlled analgesia pumps market. The growth of the patient controlled analgesia pumps market is expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of chronic diseases, and surge in demand for advanced analgesic pumps. Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries.

In addition, upsurge in incidence of pain cases due to rise in surgical procedure that requires pain management, in turn increases the requirement of affordable patient-controlled analgesic (PCA) pumps. Furthermore, rapid rise in aging population is one of the major drivers for the patient controlled analgesia pumps market. Aging is accompanied by a high susceptibility of diseases due to decreased immunity and degeneration. Globally, the geriatric population has increased significantly and is vulnerable to various disorders such as cardiovascular, stroke, diabetes, gastric diseases, and intestinal illnesses. 

Moreover, factors such as high demand of home-based healthcare, numerous applications of patient controlled analgesia pumps, rise in geriatric population, and surge in affordability in the developing economies are projected to supplement the market growth. Early diagnosis of chronic diseases at or near bedside or at home increases the chances of successful treatment and further minimizes the hospital expenditure. The home healthcare is gaining popularity as it is a cost-effective alternative to hospital-based treatments of chronic diseases. Home-based patient controlled analgesia pumps provide better and immediate results. Portability, compact and ergonomic design, and user-friendly features of analgesic pumps are key contributors to their widespread adoption in home care settings. 

The demand for patient controlled analgesia pumps is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the market. Furthermore, rise in health awareness related to several diseases and ease of accessibility boost the adoption of patient controlled analgesia pumps. Moreover, increase in promotional activities by manufacturers and growth in awareness for chronic diseases and early diagnosis among the general population are expected to fuel their adoption in the near future. Moreover, technological advancements in analgesic pumps such as wireless connectivity and high demand of infusion pumps for pain management drive the patient controlled analgesia pumps market opportunity.

However, stringent government regulations for the approval of medical devices and recall of several products due to errors while transporting the medications during infusion therapies are expected to hinders the market growth. For instance, according to the Food and Drug Administration (FDA) norms, the patient controlled analgesia pumps should be efficacious, accurate, and consistent. The procedure for obtaining a regulatory approval for infusion pumps (Class II) is stringent and time-consuming. The other disadvantage of the regulatory procedure includes high cost of these trials, which further limits the innovation in the products, and therefore small companies find it difficult to survive in the market without the support from large enterprises. This in turn decreases market competition, which leads to the high cost of the pumps. In addition, lack of awareness about using advanced infusion systems and stringent regulations imposed on product approval are likely to restrain the patient controlled analgesia pumps market forecast.

The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. The global patient controlled analgesia pumps market experienced a decline in 2021 due to global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries such as healthcare, and industrial. However, the market is anticipated to witness recovery in 2021, and show stable growth for patient controlled analgesia pumps market in the coming future. This is attributed to the increase in adoption patient controlled analgesia pumps. In addition, increase in the COVID-19 cases led to decline in the number of surgical procedures this had led to decrease in demand for patient controlled analgesia pumps Many key market players registered the decrease in their revenues from the analgesic pump segments, which was mainly due to the decline in the patient visit to the hospitals, reallocation of the healthcare resources and effect on the supply chain around the globe.

Segmental Overview

The patient controlled analgesia pumps market is segmented into type, application, end user, and region. By type, the market is categorized into electronic & wireless and mechanical. On the basis of application, the market is segregated into oncology & hematology, gastroenterology, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Type 

The market is segmented into electronic & wireless and mechanical. The electronic & wireless segment dominated the patient controlled analgesia pumps industry in 2021, owing to rise in advanced features in electronic patient controlled analgesia pumps.

Patient Controlled Analgesia Pumps Market

By Application

The market is segregated into oncology & hematology, gastroenterology, and others. The oncology & hematology segment dominated the patient controlled analgesia pumps market size in 2021, and is anticipated to continue this trend during the forecast period. This is attributed to rise in R&D activities in oncology and hematology field for analgesic pumps.

Patient Controlled Analgesia Pumps Market

 

By End User

The market is classified into hospitals, ambulatory surgical centers, and others. The others segment held the largest patient controlled analgesia pumps market share in 2021, owing to rise in number of home care setting and cancer treatment centers for several diseases this has led to increases the demand for analgesic pumps. In addition, rise in number of cancer treatment centers due to surge in prevalence of cancer disease and availability of a wide range of choice of treatment in some developing nations propels the segment growth. For instance, according to National Cancer Institute (NCI), data published in U.S. 2019, there are 71 INC-Designated Cancer Centers, located in 36 states and the District of Columbia.

Patient Controlled Analgesia Pumps Market

 
By Region
The patient controlled analgesia pumps market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the patient controlled analgesia pumps market in 2021, and is expected to maintain its dominance during the forecast period.

Presence of several major players, such as Becton, Dickinson and Company, ICU Medical, Inc., and advancement in manufacturing technology of patient controlled analgesia pumps in the region drive the growth of the market. Furthermore, presence of well-established healthcare infrastructure, high purchasing power, and rise in adoption of patient controlled analgesia pumps are expected to drive the market growth.  

Patient Controlled Analgesia Pumps Market

Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to presence of medical devices manufacturer companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Moreover, rise in personalized healthcare expenditure and adoption of high-tech based analgesic pumps drive the growth of the market. Asia-Pacific offers profitable opportunities for key players operating in the patient controlled analgesia pumps market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rise in disposable incomes, as well as well-established presence of domestic companies in the region.

In addition, rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region. Moreover, favorable reimbursements, rise in prevalence of chronic pain, and fibromyalgia also supports the market growth. Increase in number of initiatives and enhanced investments from the government for the overall development of healthcare system support the growth of infusion pumps in these developing regions. In addition, the increase in healthcare awareness about the infusion therapies and growth in per capita healthcare expenditure in the developing countries further provide opportunities for the patient controlled analgesia pumps market growth.

Competition Analysis

Competitive analysis and profiles of the major players in the patient controlled analgesia pumps, such as Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, and SCW Medicath Ltd. are provided in this report.  

Some Example Of Acquisition In The Market  

In September 2021, ICU Medical announced the acquisition of Smiths Medical to expand its product portfolio. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient controlled analgesia pumps market analysis from 2021 to 2031 to identify the prevailing patient controlled analgesia pumps market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient controlled analgesia pumps market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient controlled analgesia pumps market trends, key players, market segments, application areas, and market growth strategies.

Patient Controlled Analgesia Pumps Market Report Highlights

Aspects Details
Market Size By 2031 USD 407.9 million
Growth Rate CAGR of 3.9%
Forecast period 2021 - 2031
Report Pages 235
By Type
  • Electronic and Wireless
  • Mechanical
By Application
  • Oncology and hematology
  • Gastroenterology
  • Others
By End user
  • Hospitals
  • Ambulatory surgical centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Arcomed AG, Fresenius SE and Co. KGaA, Ace-medical, Henan Tuoren Medical Device Co., Ltd., Becton, Dickinson and Company, ICU Medical, Inc., B. Braun SE, SCW Medicath Ltd, Changzhou Medical Bioengineering Co., Ltd., Micrel Medical Devices SA
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report description

    • 1.2. Key market segments

    • 1.3. Key benefits to the stakeholders

    • 1.4. Research Methodology

      • 1.4.1. Primary research

      • 1.4.2. Secondary research

      • 1.4.3. Analyst tools and models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET OVERVIEW

    • 3.1. Market definition and scope

    • 3.2. Key findings

      • 3.2.1. Top impacting factors

      • 3.2.2. Top investment pockets

    • 3.3. Porter’s five forces analysis

      • 3.3.1. Moderate bargaining power of suppliers

      • 3.3.2. Moderate bargaining power of buyers

      • 3.3.3. Moderate threat of substitutes

      • 3.3.4. Moderate threat of new entrants

      • 3.3.5. Moderate intensity of rivalry

    • 3.4. Market dynamics

      • 3.4.1. Drivers

        • 3.4.1.1. Rise in cases of chronic pain diseases
        • 3.4.1.2. Technological advancements in analgesic pumps
        • 3.4.1.3. Increase in number of surgeries

      • 3.4.2. Restraints

        • 3.4.2.1. Lack of awareness regarding analgesia pumps
        • 3.4.2.2. Stringent government regulations

      • 3.4.3. Opportunities

        • 3.4.3.1. Lucrative growth opportunities in developing countries
        • 3.4.3.2. Development in analgesic pumps

    • 3.5. COVID-19 Impact Analysis on the market

  • CHAPTER 4: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE

    • 4.1. Overview

      • 4.1.1. Market size and forecast

    • 4.2. Electronic and Wireless

      • 4.2.1. Key market trends, growth factors and opportunities

      • 4.2.2. Market size and forecast, by region

      • 4.2.3. Market share analysis by country

    • 4.3. Mechanical

      • 4.3.1. Key market trends, growth factors and opportunities

      • 4.3.2. Market size and forecast, by region

      • 4.3.3. Market share analysis by country

  • CHAPTER 5: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION

    • 5.1. Overview

      • 5.1.1. Market size and forecast

    • 5.2. Oncology and hematology

      • 5.2.1. Key market trends, growth factors and opportunities

      • 5.2.2. Market size and forecast, by region

      • 5.2.3. Market share analysis by country

    • 5.3. Gastroenterology

      • 5.3.1. Key market trends, growth factors and opportunities

      • 5.3.2. Market size and forecast, by region

      • 5.3.3. Market share analysis by country

    • 5.4. Others

      • 5.4.1. Key market trends, growth factors and opportunities

      • 5.4.2. Market size and forecast, by region

      • 5.4.3. Market share analysis by country

  • CHAPTER 6: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER

    • 6.1. Overview

      • 6.1.1. Market size and forecast

    • 6.2. Hospitals

      • 6.2.1. Key market trends, growth factors and opportunities

      • 6.2.2. Market size and forecast, by region

      • 6.2.3. Market share analysis by country

    • 6.3. Ambulatory surgical centers

      • 6.3.1. Key market trends, growth factors and opportunities

      • 6.3.2. Market size and forecast, by region

      • 6.3.3. Market share analysis by country

    • 6.4. Others

      • 6.4.1. Key market trends, growth factors and opportunities

      • 6.4.2. Market size and forecast, by region

      • 6.4.3. Market share analysis by country

  • CHAPTER 7: PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION

    • 7.1. Overview

      • 7.1.1. Market size and forecast By Region

    • 7.2. North America

      • 7.2.1. Key trends and opportunities

      • 7.2.2. Market size and forecast, by Type

      • 7.2.3. Market size and forecast, by Application

      • 7.2.4. Market size and forecast, by End user

      • 7.2.5. Market size and forecast, by country

        • 7.2.5.1. U.S.
          • 7.2.5.1.1. Key market trends, growth factors and opportunities
          • 7.2.5.1.2. Market size and forecast, by Type
          • 7.2.5.1.3. Market size and forecast, by Application
          • 7.2.5.1.4. Market size and forecast, by End user
        • 7.2.5.2. Canada
          • 7.2.5.2.1. Key market trends, growth factors and opportunities
          • 7.2.5.2.2. Market size and forecast, by Type
          • 7.2.5.2.3. Market size and forecast, by Application
          • 7.2.5.2.4. Market size and forecast, by End user
        • 7.2.5.3. Mexico
          • 7.2.5.3.1. Key market trends, growth factors and opportunities
          • 7.2.5.3.2. Market size and forecast, by Type
          • 7.2.5.3.3. Market size and forecast, by Application
          • 7.2.5.3.4. Market size and forecast, by End user
    • 7.3. Europe

      • 7.3.1. Key trends and opportunities

      • 7.3.2. Market size and forecast, by Type

      • 7.3.3. Market size and forecast, by Application

      • 7.3.4. Market size and forecast, by End user

      • 7.3.5. Market size and forecast, by country

        • 7.3.5.1. Germany
          • 7.3.5.1.1. Key market trends, growth factors and opportunities
          • 7.3.5.1.2. Market size and forecast, by Type
          • 7.3.5.1.3. Market size and forecast, by Application
          • 7.3.5.1.4. Market size and forecast, by End user
        • 7.3.5.2. France
          • 7.3.5.2.1. Key market trends, growth factors and opportunities
          • 7.3.5.2.2. Market size and forecast, by Type
          • 7.3.5.2.3. Market size and forecast, by Application
          • 7.3.5.2.4. Market size and forecast, by End user
        • 7.3.5.3. UK
          • 7.3.5.3.1. Key market trends, growth factors and opportunities
          • 7.3.5.3.2. Market size and forecast, by Type
          • 7.3.5.3.3. Market size and forecast, by Application
          • 7.3.5.3.4. Market size and forecast, by End user
        • 7.3.5.4. Italy
          • 7.3.5.4.1. Key market trends, growth factors and opportunities
          • 7.3.5.4.2. Market size and forecast, by Type
          • 7.3.5.4.3. Market size and forecast, by Application
          • 7.3.5.4.4. Market size and forecast, by End user
        • 7.3.5.5. Spain
          • 7.3.5.5.1. Key market trends, growth factors and opportunities
          • 7.3.5.5.2. Market size and forecast, by Type
          • 7.3.5.5.3. Market size and forecast, by Application
          • 7.3.5.5.4. Market size and forecast, by End user
        • 7.3.5.6. Rest of Europe
          • 7.3.5.6.1. Key market trends, growth factors and opportunities
          • 7.3.5.6.2. Market size and forecast, by Type
          • 7.3.5.6.3. Market size and forecast, by Application
          • 7.3.5.6.4. Market size and forecast, by End user
    • 7.4. Asia-Pacific

      • 7.4.1. Key trends and opportunities

      • 7.4.2. Market size and forecast, by Type

      • 7.4.3. Market size and forecast, by Application

      • 7.4.4. Market size and forecast, by End user

      • 7.4.5. Market size and forecast, by country

        • 7.4.5.1. Japan
          • 7.4.5.1.1. Key market trends, growth factors and opportunities
          • 7.4.5.1.2. Market size and forecast, by Type
          • 7.4.5.1.3. Market size and forecast, by Application
          • 7.4.5.1.4. Market size and forecast, by End user
        • 7.4.5.2. China
          • 7.4.5.2.1. Key market trends, growth factors and opportunities
          • 7.4.5.2.2. Market size and forecast, by Type
          • 7.4.5.2.3. Market size and forecast, by Application
          • 7.4.5.2.4. Market size and forecast, by End user
        • 7.4.5.3. India
          • 7.4.5.3.1. Key market trends, growth factors and opportunities
          • 7.4.5.3.2. Market size and forecast, by Type
          • 7.4.5.3.3. Market size and forecast, by Application
          • 7.4.5.3.4. Market size and forecast, by End user
        • 7.4.5.4. Australia
          • 7.4.5.4.1. Key market trends, growth factors and opportunities
          • 7.4.5.4.2. Market size and forecast, by Type
          • 7.4.5.4.3. Market size and forecast, by Application
          • 7.4.5.4.4. Market size and forecast, by End user
        • 7.4.5.5. South Korea
          • 7.4.5.5.1. Key market trends, growth factors and opportunities
          • 7.4.5.5.2. Market size and forecast, by Type
          • 7.4.5.5.3. Market size and forecast, by Application
          • 7.4.5.5.4. Market size and forecast, by End user
        • 7.4.5.6. Rest of Asia-Pacific
          • 7.4.5.6.1. Key market trends, growth factors and opportunities
          • 7.4.5.6.2. Market size and forecast, by Type
          • 7.4.5.6.3. Market size and forecast, by Application
          • 7.4.5.6.4. Market size and forecast, by End user
    • 7.5. LAMEA

      • 7.5.1. Key trends and opportunities

      • 7.5.2. Market size and forecast, by Type

      • 7.5.3. Market size and forecast, by Application

      • 7.5.4. Market size and forecast, by End user

      • 7.5.5. Market size and forecast, by country

        • 7.5.5.1. Brazil
          • 7.5.5.1.1. Key market trends, growth factors and opportunities
          • 7.5.5.1.2. Market size and forecast, by Type
          • 7.5.5.1.3. Market size and forecast, by Application
          • 7.5.5.1.4. Market size and forecast, by End user
        • 7.5.5.2. Saudi Arabia
          • 7.5.5.2.1. Key market trends, growth factors and opportunities
          • 7.5.5.2.2. Market size and forecast, by Type
          • 7.5.5.2.3. Market size and forecast, by Application
          • 7.5.5.2.4. Market size and forecast, by End user
        • 7.5.5.3. South Africa
          • 7.5.5.3.1. Key market trends, growth factors and opportunities
          • 7.5.5.3.2. Market size and forecast, by Type
          • 7.5.5.3.3. Market size and forecast, by Application
          • 7.5.5.3.4. Market size and forecast, by End user
        • 7.5.5.4. Rest of LAMEA
          • 7.5.5.4.1. Key market trends, growth factors and opportunities
          • 7.5.5.4.2. Market size and forecast, by Type
          • 7.5.5.4.3. Market size and forecast, by Application
          • 7.5.5.4.4. Market size and forecast, by End user
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top winning strategies

    • 8.3. Product Mapping of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top player positioning, 2021

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Ace-medical

      • 9.1.1. Company overview

      • 9.1.2. Key Executives

      • 9.1.3. Company snapshot

      • 9.1.4. Operating business segments

      • 9.1.5. Product portfolio

    • 9.2. Arcomed AG

      • 9.2.1. Company overview

      • 9.2.2. Key Executives

      • 9.2.3. Company snapshot

      • 9.2.4. Operating business segments

      • 9.2.5. Product portfolio

    • 9.3. B. Braun SE

      • 9.3.1. Company overview

      • 9.3.2. Key Executives

      • 9.3.3. Company snapshot

      • 9.3.4. Operating business segments

      • 9.3.5. Product portfolio

      • 9.3.6. Business performance

    • 9.4. Becton, Dickinson and Company

      • 9.4.1. Company overview

      • 9.4.2. Key Executives

      • 9.4.3. Company snapshot

      • 9.4.4. Operating business segments

      • 9.4.5. Product portfolio

      • 9.4.6. Business performance

    • 9.5. Henan Tuoren Medical Device Co., Ltd.

      • 9.5.1. Company overview

      • 9.5.2. Key Executives

      • 9.5.3. Company snapshot

      • 9.5.4. Operating business segments

      • 9.5.5. Product portfolio

    • 9.6. ICU Medical, Inc.

      • 9.6.1. Company overview

      • 9.6.2. Key Executives

      • 9.6.3. Company snapshot

      • 9.6.4. Operating business segments

      • 9.6.5. Product portfolio

      • 9.6.6. Business performance

      • 9.6.7. Key strategic moves and developments

    • 9.7. Micrel Medical Devices SA

      • 9.7.1. Company overview

      • 9.7.2. Key Executives

      • 9.7.3. Company snapshot

      • 9.7.4. Operating business segments

      • 9.7.5. Product portfolio

    • 9.8. Fresenius SE and Co. KGaA

      • 9.8.1. Company overview

      • 9.8.2. Key Executives

      • 9.8.3. Company snapshot

      • 9.8.4. Operating business segments

      • 9.8.5. Product portfolio

      • 9.8.6. Business performance

    • 9.9. Changzhou Medical Bioengineering Co., Ltd.

      • 9.9.1. Company overview

      • 9.9.2. Key Executives

      • 9.9.3. Company snapshot

      • 9.9.4. Operating business segments

      • 9.9.5. Product portfolio

    • 9.10. SCW Medicath Ltd

      • 9.10.1. Company overview

      • 9.10.2. Key Executives

      • 9.10.3. Company snapshot

      • 9.10.4. Operating business segments

      • 9.10.5. Product portfolio

  • LIST OF TABLES

  • TABLE 01. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 02. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 03. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 04. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 05. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 06. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 07. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 08. GLOBAL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 09. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. NORTH AMERICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 63. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 65. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 66. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 67. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 68. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 69. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 70. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 71. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 72. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 73. LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 74. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 75. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 76. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 77. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 78. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 79. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 80. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 81. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 82. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 83. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
    TABLE 84. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 85. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 86. ACE-MEDICAL: KEY EXECUTIVES
    TABLE 87. ACE-MEDICAL: COMPANY SNAPSHOT
    TABLE 88. ACE-MEDICAL: PRODUCT SEGMENTS
    TABLE 89. ACE-MEDICAL: PRODUCT PORTFOLIO
    TABLE 90. ARCOMED AG: KEY EXECUTIVES
    TABLE 91. ARCOMED AG: COMPANY SNAPSHOT
    TABLE 92. ARCOMED AG: PRODUCT SEGMENTS
    TABLE 93. ARCOMED AG: PRODUCT PORTFOLIO
    TABLE 94. B. BRAUN SE: KEY EXECUTIVES
    TABLE 95. B. BRAUN SE: COMPANY SNAPSHOT
    TABLE 96. B. BRAUN SE: PRODUCT SEGMENTS
    TABLE 97. B. BRAUN SE: PRODUCT PORTFOLIO
    TABLE 98. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
    TABLE 99. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
    TABLE 100. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
    TABLE 101. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
    TABLE 102. HENAN TUOREN MEDICAL DEVICE CO., LTD.: KEY EXECUTIVES
    TABLE 103. HENAN TUOREN MEDICAL DEVICE CO., LTD.: COMPANY SNAPSHOT
    TABLE 104. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT SEGMENTS
    TABLE 105. HENAN TUOREN MEDICAL DEVICE CO., LTD.: PRODUCT PORTFOLIO
    TABLE 106. ICU MEDICAL, INC.: KEY EXECUTIVES
    TABLE 107. ICU MEDICAL, INC.: COMPANY SNAPSHOT
    TABLE 108. ICU MEDICAL, INC.: PRODUCT SEGMENTS
    TABLE 109. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
    TABLE 110. ICU MEDICAL, INC.: KEY STRATERGIES
    TABLE 111. MICREL MEDICAL DEVICES SA: KEY EXECUTIVES
    TABLE 112. MICREL MEDICAL DEVICES SA: COMPANY SNAPSHOT
    TABLE 113. MICREL MEDICAL DEVICES SA: PRODUCT SEGMENTS
    TABLE 114. MICREL MEDICAL DEVICES SA: PRODUCT PORTFOLIO
    TABLE 115. FRESENIUS SE AND CO. KGAA: KEY EXECUTIVES
    TABLE 116. FRESENIUS SE AND CO. KGAA: COMPANY SNAPSHOT
    TABLE 117. FRESENIUS SE AND CO. KGAA: PRODUCT SEGMENTS
    TABLE 118. FRESENIUS SE AND CO. KGAA: PRODUCT PORTFOLIO
    TABLE 119. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: KEY EXECUTIVES
    TABLE 120. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: COMPANY SNAPSHOT
    TABLE 121. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT SEGMENTS
    TABLE 122. CHANGZHOU MEDICAL BIOENGINEERING CO., LTD.: PRODUCT PORTFOLIO
    TABLE 123. SCW MEDICATH LTD: KEY EXECUTIVES
    TABLE 124. SCW MEDICATH LTD: COMPANY SNAPSHOT
    TABLE 125. SCW MEDICATH LTD: PRODUCT SEGMENTS
    TABLE 126. SCW MEDICATH LTD: PRODUCT PORTFOLIO
  • LIST OF FIGURES

  • FIGURE 01. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
    FIGURE 02. SEGMENTATION OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031
    FIGURE 03. TOP INVESTMENT POCKETS IN PATIENT CONTROLLED ANALGESIA PUMPS MARKET (2022-2031)
    FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
    FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
    FIGURE 06. MODERATE THREAT OF SUBSTITUTES
    FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
    FIGURE 08. MODERATE INTENSITY OF RIVALRY
    FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPATIENT CONTROLLED ANALGESIA PUMPS MARKET
    FIGURE 10. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY TYPE, 2021(%)
    FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ELECTRONIC AND WIRELESS, BY COUNTRY 2021-2031(%)
    FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR MECHANICAL, BY COUNTRY 2021-2031(%)
    FIGURE 13. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY APPLICATION, 2021(%)
    FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR ONCOLOGY AND HEMATOLOGY, BY COUNTRY 2021-2031(%)
    FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR GASTROENTEROLOGY, BY COUNTRY 2021-2031(%)
    FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 17. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, BY END USER, 2021(%)
    FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
    FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
    FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT CONTROLLED ANALGESIA PUMPS MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
    FIGURE 21. PATIENT CONTROLLED ANALGESIA PUMPS MARKET BY REGION, 2021
    FIGURE 22. U.S. PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 23. CANADA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 24. MEXICO PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 25. GERMANY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 26. FRANCE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 27. UK PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 28. ITALY PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 29. SPAIN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 30. REST OF EUROPE PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 31. JAPAN PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 32. CHINA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 33. INDIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 34. AUSTRALIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 35. SOUTH KOREA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 36. REST OF ASIA-PACIFIC PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 37. BRAZIL PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 38. SAUDI ARABIA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 39. SOUTH AFRICA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 40. REST OF LAMEA PATIENT CONTROLLED ANALGESIA PUMPS MARKET, 2021-2031 ($MILLION)
    FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 45. COMPETITIVE DASHBOARD
    FIGURE 46. COMPETITIVE HEATMAP: PATIENT CONTROLLED ANALGESIA PUMPS MARKET
    FIGURE 47. TOP PLAYER POSITIONING, 2021
    FIGURE 48. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
    FIGURE 49. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 50. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 51. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 52. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 53. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 54. ICU MEDICAL, INC.: NET REVENUE, 2019-2021 ($MILLION)
    FIGURE 55. ICU MEDICAL, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 56. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2021 (%)
    FIGURE 57. FRESENIUS SE AND CO. KGAA: NET SALES, 2019-2021 ($MILLION)
    FIGURE 58. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY SEGMENT, 2021 (%)
    FIGURE 59. FRESENIUS SE AND CO. KGAA: REVENUE SHARE BY REGION, 2021 (%)

 
 

This section provides various opinions of top-level CXOs in the global patient controlled analgesia pumps market. According to the insights of CXOs, the global patient controlled analgesia pumps market is expected to exhibit high growth potential attributable to factors such as increase in demand for patient controlled analgesic pumps and rise in investments for analgesic pumps. Moreover, rise in number of surgeries requires analgesic pumps to manage the pain thereby, contribute towards the market growth.? 

CXOs further added that patient controlled analgesic pumps includes the advanced features such as efficient pain management, bar-code readers, computer-based pump programming systems, and dose error reduction devices. Thus, such advanced features in analgesic pumps lead to increase in demand for patient controlled analgesic pumps and drive the market growth.? 

Furthermore, North America is expected to witness largest growth, in terms of revenue, owing to increase in adoption of patient controlled analgesic pumps and rise in healthcare infrastructure. Upsurge in healthcare expenditure in the emerging economies is anticipated to offer lucrative opportunities for the market expansion. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in distribution network of patient controlled analgesic pumps and increase in investments for manufacturing patient controlled analgesic pumps during the forecast period.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. Rise in number of surgeries such as oncology surgery, and others requires the anesthesia pump to manage the pain this has led to drive the market growth.

A. Oncology and hematology is the leading application of patient controlled analgesia pumps market.

A. North America is the largest regional market for patient controlled analgesia pumps market.

A. The patient controlled analgesia pumps market valued for $277.67 million in 2021 and is estimated to reach $407.89 million by 2031, exhibiting a CAGR of 3.9% from 2022 to 2031

A. Major Key players that operate in the global patient controlled analgesia pumps market are Ace-medical, Arcomed AG, B. Braun SE, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE and Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, SCW Medicath Ltd.

A. 2021 is the base year of patient controlled analgesia pumps market.

A. 2022-2031 is the forecast period of patient controlled analgesia pumps market.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Patient Controlled Analgesia Pumps Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Jan 2024 - Jan 2025)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2024 - Jan 2025)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2024 - Jan 2025)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2024 - Jan 2025)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Jan 2024 - Jan 2025)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers